U.S. Pharma Stock News

Enact Holdings (ACT) has opened Q1 2026 with total revenue of US$312.1 million and basic EPS of US$1.18, alongside trailing twelve month revenue of about US$1.2 billion and basic EPS of US$4.64. Over recent quarters, revenue has moved in a tight band around US$300 million per quarter, while basic EPS has held around the US$1.10 to US$1.23 range. This sets up Q1 as part of a consistent top line and earnings profile that investors can benchmark against the stock's current US$43.06 share price...

Carlsmed (CARL) opened Q1 2026 with revenue of US$16.1 million, a basic EPS loss of US$0.32 and trailing twelve month revenue of US$56.4 million alongside a trailing basic EPS loss of US$1.70, setting a clear top line growth story against ongoing losses. Over the past year, the company has seen quarterly revenue move from US$10.2 million in Q1 2025 to US$16.1 million in Q1 2026, while quarterly basic EPS moved from a loss of US$1.47 to a loss of US$0.32. Trailing twelve month revenue rose...

Q1 2026 earnings snapshot Revolve Group (RVLV) opened 2026 with Q1 revenue of US$342.9 million and basic EPS of US$0.20, while trailing twelve month revenue stood at about US$1.27 billion and EPS at US$0.90. Over recent quarters, the company has seen revenue range from US$293.7 million in Q4 2024 to US$324.4 million in Q4 2025, with basic EPS moving between US$0.14 and US$0.30 across the 2025 fiscal year. This gives investors a fuller view of how the latest quarter fits into its earnings...

In April 2026, Procter & Gamble reported higher quarterly sales of US$21,235 million and net income of US$3,932 million, with diluted EPS from continuing operations of US$1.63, all above the prior year’s levels and supported by volume growth and new product launches across its portfolio. This combination of stronger volumes, innovation-led growth and ongoing cost-control efforts, despite pressures from higher energy and shipping costs linked to Middle East tensions, reinforced confidence in...

What Equinix’s latest earnings mean for stock watchers Equinix (EQIX) is back in focus after reporting first quarter net income of US$415 million and higher earnings per share, alongside raised 2026 revenue guidance and a confirmed quarterly dividend. See our latest analysis for Equinix. At a share price of US$1,087.55, the stock has a 90 day share price return of 34.67% and a 1 year total shareholder return of 27.54%, suggesting momentum has been building as investors react to stronger...

Westlake Chemical Partners (WLKP) opened 2026 with Q1 revenue of US$305.7 million and basic EPS of US$0.40, alongside trailing 12 month revenue of about US$1.2 billion and EPS of US$1.64 that reflect 6.7% revenue growth and 10.3% EPS growth over the past year. Over that period, revenue has moved from US$1.09 billion to US$1.23 billion, while EPS has shifted from US$1.49 to US$1.64, giving investors a clearer read on how the current quarter fits into the last year of results. With net margin...

Navitas Semiconductor (NVTS) kicked off Q1 2026 with revenue of US$8.6 million and a basic EPS loss of US$0.15, while over the trailing twelve months it posted revenue of US$40.5 million and a basic EPS loss of US$0.62. Over recent quarters the company has seen revenue move from US$14.0 million and a basic EPS loss of US$0.09 in Q1 2025 to US$7.3 million with a basic EPS loss of US$0.14 in Q4 2025. This frames a story where topline growth expectations and margin pressure are pulling in...

BrightView Holdings (BV) opened Q2 2026 with revenue of US$702.9 million and a basic EPS loss of US$0.08, while trailing 12 month figures show revenue of about US$2.7 billion and a small net loss of US$4.7 million. Over recent quarters, revenue has moved from US$662.5 million in Q2 2025 to US$702.9 million in Q2 2026, with EPS swinging between a loss of US$0.20 in Q1 2025 and a profit of US$0.16 in Q3 2025 before returning to a loss this quarter. This sets up a mixed picture for margins and...

Arista Networks (ANET) has opened 2026 with Q1 revenue of US$2.7 billion and basic EPS of US$0.81, setting the tone for how the rest of the year may unfold. Over recent quarters the company has seen revenue move from US$2.0 billion in Q1 2025 to US$2.7 billion in Q1 2026, while basic EPS has shifted from US$0.65 to US$0.81 across the same period, giving you a clear view of how the top and bottom line are tracking ahead of this latest report. With trailing net profit margins still near the...

Geron (GERN) opened 2026 with Q1 revenue of US$51.8 million, a basic EPS loss of US$0.005, and net income loss of US$3.6 million. This set the tone for another earnings season where growth and profitability stay in focus. Over the last year the company has seen revenue move from US$76.9 million in Q4 2024 to US$196.1 million on a trailing twelve month basis, while the trailing basic EPS loss narrowed from US$0.27 to US$0.10. This leaves investors weighing ongoing losses against improving...

BJ's Restaurants (BJRI) opened 2026 with Q1 revenue of US$358.1 million and basic EPS of US$0.43, alongside trailing 12 month revenue of about US$1.4b and EPS of US$2.05 that reflect reported earnings growth of 98.1% year over year and a 5 year annualized earnings growth rate of 66.7%. Over the last few quarters the company has seen revenue move from US$347.9 million and EPS of US$0.59 in Q1 2025 to US$355.4 million and EPS of US$0.60 in Q4 2025, before landing at the current Q1 2026 levels...

Why EQT stock is back in focus after Q1 2026 earnings EQT (EQT) is drawing fresh attention after fiscal Q1 2026 results, where sales volumes topped prior guidance and adjusted EPS rose year over year, helping lift revenue and spark a recent share price reaction. See our latest analysis for EQT. Despite the positive Q1 2026 surprise, EQT's short term share price performance has cooled, with a 1 month share price return of 5.03% and a 1 week share price decline of 2.96%, while longer term total...

EOG Resources (EOG) opened 2026 with Q1 revenue of US$6.8b and basic EPS of US$3.72, supported by net income of US$1.98b as the stock trades around US$134.69. Over recent periods, total revenue has moved between US$5.4b and US$6.8b a quarter while basic EPS has ranged from about US$1.31 to US$3.72, providing a view of how the earnings line flexes with the top line. Margins are in focus for this release, with investors weighing solid profitability against how efficiently EOG is converting...

PennyMac Mortgage Investment Trust (PMT) opened 2026 with Q1 total revenue of US$82.1 million and basic EPS of US$0.16, setting a quieter tone after a stronger run through 2025. Over the last year, the stock has seen quarterly revenue range from US$145.3 million to US$215.6 million and basic EPS swing between a small loss of US$0.04 and a high of US$0.55, while trailing twelve month EPS reached US$1.16 on revenue of US$758.8 million. Taken together, the latest figures point to a period where...

Why Deere’s new CFO matters for shareholders Deere (DE) just reshaped its finance leadership, elevating Brent Norwood to senior vice president and chief financial officer on May 1, a move drawing attention ahead of the May 21 earnings report. For you as an investor, this kind of transition sits at the intersection of corporate oversight and capital allocation, two areas that can influence how consistently a company funds growth projects, manages its balance sheet, and returns cash to...

UroGen Pharma (URGN) opened 2026 with Q1 revenue of US$51.0 million and a basic EPS loss of US$0.47, alongside a net income loss of US$23.6 million, setting a clear marker for how the business is scaling while remaining loss making. The company has seen quarterly revenue move from US$20.3 million in Q1 2025 to US$51.0 million in Q1 2026, while basic EPS over that span ranged from a loss of US$1.05 in Q2 2025 to a loss of US$0.47 in the latest quarter. As a result, investors are getting a...

Q1 2026 results snapshot Recursion Pharmaceuticals (RXRX) has kicked off Q1 2026 with revenue of US$6.5 million, basic EPS of US$0.22 loss, and trailing twelve month revenue of US$66.4 million against a trailing net loss of US$559.8 million. Over recent quarters, the company has seen revenue move between US$4.5 million and US$35.5 million, while quarterly basic EPS has ranged from a loss of US$0.20 to a loss of US$0.53 as the business continues to invest heavily and run at sizable losses,...

Solid Power (SLDP) has released its Q1 2026 numbers, with revenue at US$2.1 million and a basic EPS loss of US$0.06, setting the stage for another quarter where the income statement is firmly in the red. The company has seen quarterly revenue move from US$6.0 million in Q1 2025 to US$2.1 million in Q1 2026, while basic EPS has shifted from a loss of US$0.08 to a loss of US$0.06 over the same period, giving investors a mixed read on the top line and per share performance. With consensus still...

Loma Negra Compañía Industrial Argentina Sociedad Anónima (NYSE:LOMA) opened 2026 with Q1 results that put revenue at about ARS 218.7b and basic EPS at ARS 351.37, setting a clear marker for how the year is starting to shape up. Over the past few quarters, the company has seen revenue move from about ARS 279.4b in Q4 2024 to ARS 172.9b in Q1 2025 and then to ARS 270.6b in Q4 2025. Basic EPS shifted from ARS 360.89 to ARS 195.07 and then to ARS 64.39, so this latest print lands against a...

BioCryst Pharmaceuticals (BCRX) opened 2026 with Q1 revenue of US$156.4 million and a basic EPS loss of US$2.98, compared with Q1 2025 revenue of US$145.5 million and essentially breakeven EPS of US$0.00. Over the same period, trailing 12 month EPS shifted from a profit of US$1.26 to a loss of US$2.10. Over the past year, revenue on a trailing 12 month basis moved from US$503.5 million to US$885.7 million, while net income moved from a profit of US$263.9 million in 2025 Q4 to a loss of...

Northwest Natural Holding (NWN) has kicked off Q1 2026 with revenue of US$490.4 million and basic EPS of US$2.33, against trailing 12 month revenue of US$1.3 billion and EPS of about US$2.98, alongside earnings growth of 19.4% over the past year. The company has seen quarterly revenue range from US$164.7 million to US$494.3 million over the last five reported periods, with basic EPS moving between a loss of US$0.73 and a high of roughly US$2.33. This sets up Q1 as a period where the margin...

Kennametal (KMT) Q3 2026 earnings snapshot Kennametal (KMT) has reported Q3 2026 revenue of US$592.6 million and basic EPS of US$0.76 on net income of US$58.2 million, alongside 14.6% earnings growth and a net profit margin that improved to 5.4% over the past year. The company’s revenue increased from US$482.1 million in Q2 2025 to US$529.5 million in Q2 2026 and then to US$592.6 million in the latest quarter. Over the same period, quarterly EPS rose from US$0.23 to US$0.44 and then to...

EyePoint Pharmaceuticals (EYPT) opened 2026 with Q1 revenue of US$0.7 million, a basic EPS loss of US$0.99 per share and a net income loss of US$84.8 million, setting a clear tone for how profitability is tracking into the new year. The company has seen quarterly revenue move from US$24.5 million in Q1 2025 to US$0.7 million in Q1 2026, while quarterly basic EPS shifted from a loss of US$0.65 to a loss of US$0.99. The latest print keeps the focus squarely on how much cash the business is...

Par Pacific Holdings (PARR) Q1 2026 earnings snapshot Par Pacific Holdings (PARR) opened 2026 with Q1 revenue of $1.8 billion and basic EPS of $1.12, providing a clear view of how the business is currently earning its way after a period of volatility. Over the last six quarters, revenue has moved between $1.7 billion and $2.0 billion, while quarterly basic EPS has ranged from a loss of $0.57 to a high of $5.29. This gives investors a wide spectrum of earnings outcomes to consider. With...